Costa Rica vs Rwanda: Patent applications, residents
Patent applications, residents over time
- Costa Rica
- Rwanda
How they compare
Costa Rica currently reports 15 against 14 in Rwanda, a difference of 1.
That makes Costa Rica's figure about 1.1 times Rwanda's.
The two have swapped places 2 times across 8 shared years of data; in 1988 it was Costa Rica ahead.
Costa Rica ranks 99th and Rwanda ranks 100th of 135 countries.
Costa Rica has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Costa Rica | Rwanda | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 10 | 1 | 9 | Costa Rica |
| 2010s | 12.83 | 10.5 | 2.33 | Costa Rica |
| 2020s | 15 | 14 | 1 | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher patent applications, residents, Costa Rica or Rwanda?
- Costa Rica, at 15 against 14 in Rwanda as of 2021.
- What is the difference in patent applications, residents between Costa Rica and Rwanda?
- 1, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Rwanda?
- 8 years are reported by both, from 1988 to 2021.
- How do Costa Rica and Rwanda rank globally for patent applications, residents?
- Costa Rica ranks 99th and Rwanda ranks 100th of 135 countries.
- Where does this data come from?
- WIPO Patent Report: Statistics on Worldwide Patent Activity, World Intellectual Property Organization (WIPO), note: The International Bureau of WIPO assumes no responsibility with respect to the trans, published as Patent applications, residents. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Patent applications are worldwide patent applications filed through the Patent Cooperation Treaty procedure or with a national patent office for exclusive rights for an invention--a product or process that provides a new way of doing something or offers a new technical solution to a problem. A patent provides protection for the invention to the owner of the patent for a limited period, generally 20 years.